SHR0302 Alkali Gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHR0302 Alkali Gel, covering 2025-08-01 to 2025-08-01. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetic Profile of Single and Multiple Dose Escalation Topical Dermal Administration of SHR0302 Alkali Gel in Healthy Subjects [Phase 1]